Skip to main content

Series B Biopharma Companies

Explore 97 biopharma startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
97
Total Funding
$1.4B
Avg Funding
$54.2M
Cities
21

Export 97 Series B Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Los Angeles, United States
$30.0M
raised

PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$12.0M
raised

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$16.3M
raised

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$67.0M
raised

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$105.0M
raised

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Aug 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Tel Aviv, Israel
$80.0M
raised

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Jul 2024
Series B

Founder Contacts

41,000+ verified contacts

$10.0M
raised

A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint

Jul 2024
Series B

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$51.4M
raised

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Jun 2024
Series B

Founder Contacts

41,000+ verified contacts

Fishers, United States
$42.9M
raised

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$712K
raised

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$6.2M
raised

AceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$132.0M
raised

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Apr 2024
Series B

Founder Contacts

41,000+ verified contacts

Niigata, Japan
$3.2M
raised

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

The Woodlands, United States
$6.6M
raised

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Carmel, United States
$30.0M
raised

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$56.0M
raised

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Concord, United States
$75.0M
raised

Our purpose is to make every pregnancy around the world safer.

Jan 2024
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

Dec 2023
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$66.0M
raised

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

Dec 2023
Series B

Founder Contacts

41,000+ verified contacts

Morrisville, United States
$45.3M
raised

Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.

Nov 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 97 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Watertown, United States
$175.0M
raised

Mariana Oncology is a biotechnology research industry.

Sep 2023
Series B

Founder Contacts

41,000+ verified contacts

Seoul, South Korea
$4.5M
raised

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$123.0M
raised

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Mar 2023
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$193.0M
raised

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

Feb 2023
Series B

Founder Contacts

41,000+ verified contacts

Little Chesterford, United Kingdom
$24.1M
raised

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Feb 2023
Series B

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 97 companies

Ready to Connect with Series B Biopharma Startups?

Get verified founder emails, funding details, and company data for 97 series b biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

97 Biopharma Series B Startups (November 2026) — Page 3 | VCBacked